BeiGene Financial Statements From 2010 to 2024
688235 Stock | 181.38 5.38 3.06% |
Gross Profit -511.1 M | Profit Margin (0.26) | Market Capitalization 169.5 B | Enterprise Value Revenue 6.3554 | Revenue 23.5 B |
BeiGene Total Revenue |
|
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Tax Provision of 29.8 M, Net Interest Income of 77.7 M or Interest Income of 1.7 M, as well as many indicators such as . BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
BeiGene | Select Account or Indicator |
BeiGene Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BeiGene Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BeiGene Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
BeiGene Fundamental Market Drivers
Forward Price Earnings | 526.3158 |
About BeiGene Financial Statements
BeiGene stakeholders use historical fundamental indicators, such as BeiGene's revenue or net income, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Revenue | 2.5 B | 1.3 B | |
Cost Of Revenue | 379.9 M | 304.1 M |
Currently Active Assets on Macroaxis
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out the analysis of BeiGene Correlation against competitors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.